Neurogenic bladder in Lambert-Eaton myasthenic syndrome and its response to 3,4-diaminopyridine

Journal of the Neurological Sciences

Volumn 183, Issue 1, 2001, Pages 1-4

  Satoh, Katsuya ^a   Motomura, Masakatsu ^a   Suzu, Hiroshi ^a   Nakao, Yoko ^b   Fujimoto, Takeshi ^a   Fukuda, Taku ^a   Nakane, Shunya ^a   Nakamura, Tatsufumi ^a   Eguchi, Katsumi ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Nagasaki Kita Hospital   (Japan)

Author keywords

3,4 Diaminopyridine; Autoantibodies; Autonomic dysfunction; Lambert Eaton myasthenic syndrome; Neurogenic bladder; P Q type voltage gated calcium channel

Indexed keywords

3,4 DIAMINOPYRIDINE; NICOTINIC RECEPTOR; SYNAPTOTAGMIN;

AGED; ARTICLE; AUTONOMIC DYSFUNCTION; CASE REPORT; EATON LAMBERT SYNDROME; FEMALE; HUMAN; MICTURITION; MUSCLE WEAKNESS; NEUROGENIC BLADDER; NEUROTRANSMISSION; PRIORITY JOURNAL; URODYNAMICS; XEROSTOMIA;

4-AMINOPYRIDINE; AGED; ELECTROMYOGRAPHY; FEMALE; HUMANS; LAMBERT-EATON MYASTHENIC SYNDROME; URINARY BLADDER, NEUROGENIC;

EID: 0035862705     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(00)00460-3     Document Type: Article

References (23)

1. The Lambert-Eaton myasthenic syndrome. A review of 50 cases
2. Myasthenia and malignant intrathoracic tumor
3. Autonomic dysfunction in Lambert-Eaton myasthenic syndrome
4. Autonomic dysfunction in the Lambert-Eaton myasthenic syndrome: serologic and clinical correlates
5. Clinical, neurophysiological and morphological findings in Eaton-Lambert syndrome
6. Specificity of ω-conotoxin MVIIC-binding and -blocking calcium channel antibodies in Lambert-Eaton myasthenic syndrome
7. Incidence of serum anti-P/Q-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome
8. Diagnostic significance of IgG, C3, and C9 at the limb muscle motor end-plate in minimal myasthenia gravis
9. A quantitative test for xerostomia. The Saxon test, an oral equivalent of the Schirmer test
10. The standardisation of terminology of lower urinary tract function. The International Continence Society Committee on Standardisation of Terminology
11. Cholinergic dysautonomia and Eaton-Lambert syndrome
12. Autonomic dysfunction and Eaton-Lambert syndrome
13. Plasmapheresis and immunosuppressive drug therapy in the Eaton-Lambert syndrome
14. Plasma exchange and immunosuppressive drug treatment in the Lambert-Eaton myasthenic syndrome
15. Effect of Lambert-Eaton myasthenic syndrome antibodies on autonomic neurons in the mouse
16. Functional evaluation of inhibition of autonomic transmitter release by autoantibody from Lambert-Eaton myasthenic syndrome
17. Antigens associated with N- and L-type calcium channels in Lambert-Eaton myasthenic syndrome
18. Calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome
19. An improved diagnostic assay for Lambert-Eaton myasthenic syndrome
20. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes
21. Antibodies to recombinant synaptotagmin and calcium channel subtypes in Lambert-Eaton myasthenic syndrome
22. Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer-related syndromes
23. 2+ channels in neurotransmission in the rat urinary bladder